Neoantigen Vaccine Design (Grade A)安全可靠的数据-AI技能。A等级。针对 Claude AI. 使用计算管道为 veterinary 患者设计个性化癌症 neoantigen 疫苗。涵盖肿瘤/正常序列组装。

— (0)

审阅者 Daniel Nikulshyn·更新 2026年7月

概览

这个技能指引了计算管道为 veterinary 患者设计个性化 neoantigen 癌症疫苗。它涵盖了肿瘤/正常序列组装、 soma Variant 呼叫、 DLA/MHC 型别、 neoantigen 预测和候选选择。此 pipeline 源自人类精准肿瘤学 veterinary 物种，考虑到狗使用 DLA 代替 HLA。这个过程涉及到肿瘤穿刺和样本收集、全基因组序列组装 (WES) 和 RNA 序列组装和计算 neoantigen 预测。这是一个研究框架而不是 DIY 协议;疫苗合成和输送需要实验室基础设施和 veterinary 观光医生审查。

主要功能

肿瘤/正常序列组装
soma Variant 呼叫
DLA/MHC 型别
neoantigen 预测
候选选择为疫苗设计

价格

模型: Free
分类: 育言活动
评分: 暂无评价

使用场景

针对动物癌症患者的个性化癌症治疗

探索基于 neoantigen 疫苗的免疫疗法选项

veterinary 肿瘤学 neoantigen 疫苗设计

使用计算管道为狗、猫或马设计个性化 neoantigen 癌症疫苗

优点 & 缺点

优点

提供了一个全面计算管道为个性化 neoantigen 癌症疫苗设计
源自人类精准肿瘤学，成功应用于犬科案例
考虑 veterinary 特异性挑战，如 DLA 型别

缺点

需要特殊实验室基础设施和 veterinary 观光医生审查
不是一个 DIY 协议;机构伦理审批是必要的
昂贵，样本准备费用通常在 $200-500

评测

登录以留下评测。

暂无评测。来当第一个吧!

问答

What data inputs are required to run the computational pipeline?

You need tumor biopsy samples and matched normal tissue, followed by whole exome sequencing (WES) and RNA sequencing. The pipeline then performs somatic variant calling, DLA/MHC typing, neoantigen prediction, and candidate selection.

Asked by Ulrik Madsen · Mar 24, 2026

What veterinary species are supported by the DLA/MHC typing feature?

The pipeline is adapted from human precision oncology to veterinary species, with specific consideration for dogs using DLA typing. While the framework can be applied to other species, it has been successfully demonstrated in canine cases.

Asked by Zara Ahmed · Mar 15, 2026

Is this tool suitable for a DIY approach or does it need professional oversight?

No, it is a research framework only. Vaccine synthesis, administration, and clinical decisions must be carried out under veterinary oncologist oversight and with institutional ethics approval; it is not a DIY protocol.

Asked by Vasyl Kovalenko · Jan 27, 2026

What is the cost for the sample preparation in this neoantigen vaccine design tool?

Sample preparation typically costs between $200 and $500, covering tumor/normal sequencing and associated laboratory work. Additional costs for vaccine synthesis and administration are not included and require separate clinical infrastructure.

Asked by Urszula Kowalczyk · Jan 11, 2026